The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: Racist exploitation or exploitation of racism?

American Journal of Public Health

Volumn 88, Issue 4, 1998, Pages 567-570

  Bayer, Ronald ^a,b  

^a Affiliated Faculty Global Institute of Public Health   (United States)

^b School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

AFRICA; ASIA; CLINICAL TRIAL; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ETHICS; RACE DIFFERENCE; SHORT SURVEY; VERTICAL TRANSMISSION;

EID: 0031853196     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.4.567     Document Type: Short Survey

References (9)

1. Angell M. The ethics of clinical research in the Third World. N Engl J Med. 1997;337:847-849.
2. Connor EM, Sperling RS, Gelber R. Protocol 076: reduction in maternal-infant transmission of HIV type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
3. Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med. 1997;337:1003-1005.
4. World Health Organization. Recommendations from the Meeting on Mother to Infant Transmission of HIV. Geneva, Switzerland, June 23-25, 1994.
5. Angell M. Tuskegee revisited. Wall Street J. October 28, 1997.
6. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med. 1997;337:853-855.
7. Laurence J. Ethical concerns in international HIV trials. The AIDS Reader. 1997;147.
8. Levine RJ. Ethics of Regulation of Clinical Research. 2nd ed. Baltimore, Md: Urban & Schwarzenberg; 1986.
9. French HW. AIDS research in Africa: juggling risks and hopes. New York Times. October 9, 1997;1.